A Novel Switching of Artificial Intelligence to Generate Simultaneously Multimodal Images to Assess Inflammation and Predict Outcomes in Ulcerative Colitis-(With Video)
- PMID: 40518924
- DOI: 10.1111/den.15067
A Novel Switching of Artificial Intelligence to Generate Simultaneously Multimodal Images to Assess Inflammation and Predict Outcomes in Ulcerative Colitis-(With Video)
Abstract
Objectives: Virtual Chromoendoscopy (VCE) is pivotal for assessing activity and predicting outcomes in Ulcerative Colitis (UC), though interobserver variability and the need for expertise persist. Artificial intelligence (AI) offers standardized VCE-based assessment. This study introduces a novel AI model to detect and simultaneously generate various endoscopic modalities, enhancing AI-driven inflammation assessment and outcome prediction in UC.
Methods: Endoscopic videos in high-definition white-light, iScan2, iScan3, and NBI from UC patients of the international PICaSSO iScan and NBI cohort (302 and 54 patients, respectively) were used to develop a neural network to identify the acquisition modality of each frame and for inter-modality image switching. 2535 frames from 169 videos of the iScan cohort were switched to different modalities and trained a deep-learning model for inflammation assessment. Subsequently, the model was tested on a subset of the iScan and NBI cohorts (72 and 51 videos, respectively). Performance in predicting endoscopic and histological activity and outcomes was evaluated.
Results: The model efficiently classified and converted images across modalities (92% accuracy). Performance in predicting endoscopic and histological remission was excellent, especially with different modalities combined in both iScan (accuracy 81.3% and 89.6%; AUROC 0.92 and 0.89 by UCEIS and PICaSSO, respectively) and the NBI cohort. Moreover, it showed a remarkable ability in predicting clinical outcomes.
Conclusions: Our multimodal "AI-switching" model innovatively detects and transitions between different endoscopic modalities, refining inflammation assessment and outcome prediction in UC by integrating model-derived images.
Keywords: artificial intelligence; ulcerative colitis; virtual chromoendoscopy.
© 2025 The Author(s). Digestive Endoscopy published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.
Similar articles
-
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis.Endoscopy. 2023 Apr;55(4):332-341. doi: 10.1055/a-1960-3645. Epub 2022 Oct 13. Endoscopy. 2023. PMID: 36228649 Free PMC article.
-
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video).Gastrointest Endosc. 2022 Jul;96(1):73-83. doi: 10.1016/j.gie.2022.02.012. Epub 2022 Feb 17. Gastrointest Endosc. 2022. PMID: 35182574
-
Application of deep learning in the diagnosis and evaluation of ulcerative colitis disease severity.Therap Adv Gastroenterol. 2023 Dec 22;16:17562848231215579. doi: 10.1177/17562848231215579. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 38144424 Free PMC article.
-
Rediscovering histology - the application of artificial intelligence in inflammatory bowel disease histologic assessment.Therap Adv Gastroenterol. 2025 Mar 17;18:17562848251325525. doi: 10.1177/17562848251325525. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40098604 Free PMC article. Review.
-
How to assess endoscopic disease activity in ulcerative colitis in 2022.Ann Gastroenterol. 2022 Sep-Oct;35(5):462-470. doi: 10.20524/aog.2022.0732. Epub 2022 Jul 11. Ann Gastroenterol. 2022. PMID: 36061162 Free PMC article. Review.
Cited by
-
Artificial intelligence in inflammatory bowel disease endoscopy - a review of current evidence and a critical perspective on future challenges.Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251350896. doi: 10.1177/17562848251350896. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40661220 Free PMC article. Review.
References
-
- D. Turner, A. Ricciuto, A. Lewis, et al., “STRIDE‐II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat‐To‐Target Strategies in IBD,” Gastroenterology 160 (2021): 1570–1583.
-
- M. Iacucci, R. Kiesslich, X. Gui, et al., “Beyond White Light: Optical Enhancement in Conjunction With Magnification Colonoscopy for the Assessment of Mucosal Healing in Ulcerative Colitis,” Endoscopy 49 (2017): 553–559.
-
- G. Santacroce, I. Zammarchi, C. K. Tan, et al., “Present and Future of Endoscopy Precision for Inflammatory Bowel Disease,” Digestive Endoscopy 36 (2024): 292–304.
-
- O. M. Nardone, Y. Snir, J. Hodson, et al., “Advanced Technology for Assessment of Endoscopic and Histological Activity in Ulcerative Colitis: A Systematic Review and Meta‐Analysis,” Therapeutic Advances in Gastroenterology 15 (2022): 175628482210925.
-
- T. Kuroki, Y. Maeda, S. Kudo, et al., “A Novel Artificial Intelligence–Assisted “Vascular Healing” Diagnosis for Prediction of Future Clinical Relapse in Patients With Ulcerative Colitis: A Prospective Cohort Study (With Video),” Gastrointestinal Endoscopy 100 (2024): 97–108.
LinkOut - more resources
Full Text Sources